Phenolic Bisabolane Sesquiterpene Derivatives from an Arctic Marine-derived Fungus Aspergillus Sydowii MNP-2

Zhiyang Fu,Xiangzhou Gong,Zhe Hu,Yujie Zhao,Huawei Zhang
DOI: https://doi.org/10.2174/0122103155279752240104050411
2024-01-01
Natural Products Journal
Abstract:Filamentous fungi in the genus Aspergillus are well known for their important roles in the production of bioactive secondary metabolites with diverse chemical structures and potential applications in the pharmaceutical industry. In this work, chemical investigation of an Arctic marine-derived strain A. sydowii MNP-2, led to the isolation of 11 phenolic bisabolane-type sesquiterpenes (PBSs, 1- 11) using various chromatographic methods. Their chemical structures were unambiguously determined by H-1 NMR spectroscopy and mass spectrometry analyses as well as comparison with literature data. It is noteworthy that compounds 1, 7 and 11 were first obtained from A. sydowii. Antimicrobial assay showed that these chemicals had no potent inhibitory effect on Staphylococcus aureus, Escherichia coli, and Candida albicans with MIC values > 16 mu g/mL. Additionally, the inhibition of nitric oxide (NO) production in lipopolysaccharide (LPS)-induced inflammation in mouse macrophages (RAW264.7) and BV2 microglial cells were all below 10% for compounds 4-6 and 8, indicating almost negligible anti-inflammatory efficacy. Among the tested compounds 4-6 and 8 for tumor-cell proliferation inhibition activities, compound 5 demonstrated the strongest inhibitory effect against human acute promyelocytic leukemia cells (HL-6) with a 44.76% inhibition rate.
What problem does this paper attempt to address?